Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gastrointestinal Cancers
Do you consider adjuvant radiation for low grade T1bN0 gallbladder adenocarcinoma with negative margins after oncologic resection?
The data is scarce- do you recommend chemotherapy only or would you consider RT for local control?
Answer from: Radiation Oncologist at Academic Institution
There are no data to support chemotherapy and especially not postoperative radiation.
Comments
Radiation Oncologist at Northeast Oklahoma Cancer Center
There is an absence of phase III data in this sett...
1171
Sign In
or
Register
to read more
4911
Related Questions
In a patient with gastroesophageal adenocarcinoma treated with neoadjuvant chemoimmunotherapy who had a good response but is unable to undergo surgery, how would you approach radiation therapy?
What treatments, after appropriate dose reductions/delays, do you offer for patients with oxaliplatin-induced cold allodynia/dysesthesia?
Would you offer any adjuvant therapy for a young patient with anal cancer s/p definitive chemoradiation and R0 resection with significant residual disease?
If a patient with initially borderline resectable pancreatic cancer receives neoadjuvant CHT followed by CRT and is ultimately deemed unresectable, do you consider an RT boost?
Given the results of PLATO anal cancer study, is 4140 cGy the new standard for early stage anal cancer?
Do you use more stringent liver constraints when treating HCC with SBRT in patients who are CP B8/9 or C?
What are your institutions' preferences on SBRT vs. histotripsy for treatment of liver metastases?
Is there increased risk from RT in patients with FAP (familial adenomatous polyposis)?
Do the results of recently presented ACCORD trial for EHC and gallbladder cancers have implications for your adjuvant treatment recommendations?
Would you hold HAI/ FUDR for SBRT of a residual liver metastasis following hepatic metastasectomy?
There is an absence of phase III data in this sett...